We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Batches of Bydureon Recalled in Europe Due to Low Vials
Batches of Bydureon Recalled in Europe Due to Low Vials
October 7, 2013
Bristol-Myers Squibb (BMS) and AstraZeneca (AZ) are recalling 10 batches of the diabetes drug Bydureon in Europe due to under-filled vials.